Step 1 topics → Microbiology → Other Streptococci and Enterococci

Other Streptococci and Enterococci

USMLE Step 1 trap: Misidentifies the portal of entry for viridans strep endocarditis as gut rather than oral cavity. Viridans strep (especially S. mutans, S. sanguinis) colonize the oropharynx and enter the bloodstream via dental procedures or poor dentition, seeding previously damaged heart valves to cause subacute bacterial endocarditis.

Other streptococci and enterococci is a high-yield USMLE Step 1 topic that trips students up because each organism has one or two facts that are exam-critical and easy to get wrong. The classic one-liner: S. gallolyticus bacteremia is never an isolated infectious finding — it is a red flag for colorectal neoplasia, and the mandatory next step after growing it from blood cultures is colonoscopy. Viridans strep, S. gallolyticus, and Enterococcus each have distinct niches, virulence patterns, and treatment implications that the exam exploits specifically. The core organisms here are alpha-hemolytic or non-hemolytic gram-positive cocci that don't fit neatly into Group A or Group B strep, which is exactly why the exam tests whether you've learned them individually rather than by exclusion.

The exam hits this material from three main angles: clinical presentation (who gets infected and why), clinical correlates that require downstream action (what does this bacteremia mean?), and treatment decisions including resistance patterns. The viridans group is almost always tested in the context of subacute bacterial endocarditis after a dental procedure — but students frequently misplace the portal of entry. S. gallolyticus is a classic 'what do you do next?' setup where bacteremia obligates you to order a colonoscopy. Enterococcal infections are tested on treatment, especially around VRE and the difference between bacteriostatic and bactericidal therapy.

The trickiest part of this topic is that each organism has one or two facts that are exam-critical, and getting any of them wrong costs you points across multiple question types. USMLE Step 1 will give you a patient with new-onset murmur after a dental cleaning, or a colonoscopy result in someone admitted for 'Strep bovis' bacteremia, or a VRE endocarditis case where you have to pick between linezolid and daptomycin. If you haven't built clean, distinct mental models for each organism, you'll second-guess yourself on all three.

From real student decks
84%have cards covering this topic
73%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Viridans strep cause endocarditis by hematogenous spread from the gut.
Right: Viridans strep (especially S. mutans, S. sanguinis) colonize the oropharynx and enter the bloodstream via dental procedures or poor dentition, seeding previously damaged heart valves to cause subacute bacterial endocarditis.
Viridans strep live in the mouth, not the gut — S. mutans is the classic cause of dental caries, and S. sanguinis and S. mutans are the most common culprits in subacute bacterial endocarditis. They enter the bloodstream during dental procedures or from chronically poor dentition, then seed previously damaged valves (rheumatic disease, congenital defects, MVP with regurgitation). If a question gives you a patient with a dental procedure and a new murmur weeks later, the organism is viridans strep and the route is oral, full stop.
Common mistake
Wrong: S. gallolyticus bacteremia is an incidental finding unrelated to gastrointestinal pathology.
Right: S. gallolyticus (formerly S. bovis) bacteremia and endocarditis are strongly associated with colorectal cancer and should prompt colonoscopy to rule out an underlying colonic lesion.
S. gallolyticus bacteremia is not incidental — it is a red flag for colorectal neoplasia, and missing this association on the exam is a costly error. The mechanism isn't fully established, but colonic tumors (and polyps) appear to provide an environment that promotes translocation of this organism. The clinical rule is: grow S. gallolyticus from blood cultures → work up the colon. The exam will present this as 'what is the most important next step?' and the answer is colonoscopy, not just antibiotics.
Common mistake
Wrong: Linezolid is bactericidal against VRE and is the preferred agent for serious VRE infections like endocarditis.
Right: Linezolid is bacteriostatic against enterococci; daptomycin (bactericidal) is preferred for serious VRE infections such as bacteremia and endocarditis.
Linezolid is bacteriostatic against enterococci, which makes it inadequate for endocarditis — a deep-seated infection where bacterial killing is required, not just growth inhibition. Daptomycin is bactericidal and is the preferred agent for serious VRE infections including bacteremia and endocarditis. This distinction matters because USMLE Step 1 will offer linezolid as an attractive distractor, and students who haven't locked in the static vs. cidal distinction will pick it.
Common mistake
Gap: Missing that enterococci are intrinsically resistant to cephalosporins and require synergy-based regimens
Enterococci are intrinsically resistant to cephalosporins and have low-level resistance to penicillin, requiring synergistic combination therapy (ampicillin + aminoglycoside) for serious infections in non-VRE strains.
Enterococci are intrinsically resistant to cephalosporins — this is not acquired resistance, it's built in, so cefazolin or ceftriaxone will not work regardless of sensitivity testing. For serious non-VRE infections (endocarditis, meningitis), the treatment is ampicillin plus an aminoglycoside because the combination is synergistically bactericidal even though ampicillin alone is only bacteriostatic against enterococci. This synergy concept is what the exam is testing when it asks why you can't just use monotherapy.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the viridans strep subgroups and their clinical niches — especially which species cause dental caries (S. mutans), which seed damaged heart valves after dental procedures (S. mutans, S. sanguinis), and that the portal of entry is the oropharynx, not the gut.
  2. Recognize that S. gallolyticus (formerly S. bovis) bacteremia or endocarditis is never just an isolated infectious finding — it is strongly associated with colorectal cancer, and the exam expects you to know that colonoscopy is the mandatory next step.
  3. Apply the correct treatment logic for enterococcal infections: non-VRE strains require ampicillin plus an aminoglycoside for serious infections (synergy), enterococci are intrinsically resistant to cephalosporins, and for VRE infections like endocarditis, daptomycin (bactericidal) is preferred over linezolid (bacteriostatic).

Can you avoid these mistakes?

A 62-year-old man undergoes a routine tooth extraction and develops fever and a new diastolic murmur 3 weeks later. Blood cultures grow alpha-hemolytic, catalase-negative gram-positive cocci that are optochin-resistant. What is the most likely species, what is the portal of entry, and what underlying cardiac condition predisposed him?
A 55-year-old woman is admitted for Streptococcus gallolyticus bacteremia. She is started on appropriate antibiotics and improves. What additional workup is mandatory before discharge, and why?
A patient with VRE endocarditis is being treated with linezolid but is not improving. What is the pharmacodynamic reason linezolid is insufficient here, and what agent should be used instead?
Why can't you treat a serious Enterococcus faecalis infection (non-VRE) with ceftriaxone alone, and what is the preferred regimen? What does 'synergy' mean in this context?

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →